KD Logo

RYTM stock rated an Overweight by Morgan Stanley

In a filing, Rhythm Pharmaceuticals Inc. revealed its Corporate Controller & CAO German Christopher Paul unloaded Company’s shares for reported $15368.0 on Apr 02 ’24. In the deal valued at $41.76 per share,368 shares were sold. As a result of this transaction, German Christopher Paul now holds 795 shares worth roughly $31609.199999999997.

Then, Shulman Joseph sold 18,235 shares, generating $735,600 in total proceeds. Upon selling the shares at $40.34, the Chief Technical Officer now owns 30 shares.

Before that, Lee Jennifer Kayden sold 18,235 shares. Rhythm Pharmaceuticals Inc. shares valued at $707,005 were divested by the EVP, Head of North America at a price of $38.77 per share. As a result of the transaction, Lee Jennifer Kayden now holds 6,852 shares, worth roughly $0.27 million.

Morgan Stanley upgraded its Rhythm Pharmaceuticals Inc. [RYTM] rating to an Overweight from a an Equal-weight in a research note published on December 19, 2023; the price target was increased to $55 from $29. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in early August from “a Neutral” to “a Buy”. Goldman revised its rating on August 08, 2022. It rated RYTM as “a Buy” which previously was an “a Neutral”.

Price Performance Review of RYTM

On Tuesday, Rhythm Pharmaceuticals Inc. [NASDAQ:RYTM] saw its stock jump 2.42% to $39.76. Over the last five days, the stock has lost -0.60%. Rhythm Pharmaceuticals Inc. shares have fallen nearly -13.51% since the year began. Nevertheless, the stocks have risen 97.12% over the past one year. While a 52-week high of $52.57 was reached on 02/12/24, a 52-week low of $15.50 was recorded on 04/19/24. SMA at 50 days reached $41.32, while 200 days put it at $34.02. A total of 0.63 million shares were traded, compared to the trading of 0.28 million shares in the previous session.

Levels Of Support And Resistance For RYTM Stock

The 24-hour chart illustrates a support level at 37.82, which if violated will result in even more drops to 35.87. On the upside, there is a resistance level at 41.49. A further resistance level may holdings at 43.21. The Relative Strength Index (RSI) on the 14-day chart is 48.72, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.32, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 50.26%. Stochastics %K at 34.30% indicates the stock is a holding.

Most Popular

[the_ad id="945"]